Search results for "Mesenchymal Stem Cell"

showing 10 items of 399 documents

Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function.

2009

Background: The systemic injection of neural stem/precursor cells (NPCs) provides remarkable amelioration of the clinicopathological features of experimental autoimmune encephalomyelitis (EAE). This is dependent on the capacity of transplanted NPCs to engage concurrent mechanisms of action within specific microenvironments in vivo. Among a wide range of therapeutic actions alternative to cell replacement, neuroprotective and immune modulatory capacities of transplanted NPCs have been described. However, lacking is a detailed understanding of the mechanisms by which NPCs exert their therapeutic plasticity. This study was designed to identify the first candidate that exemplifies and sustains …

Central Nervous SystemEncephalomyelitis Autoimmune ExperimentalCell Transplantationmedicine.medical_treatmentScienceAutoimmunityNeurological Disorders/Multiple Sclerosis and Related DisordersBiologyMiceImmune systemPrecursor cellmedicineotorhinolaryngologic diseasesAnimalsLymph nodeInflammationNeuronsMultidisciplinaryStem CellsExperimental autoimmune encephalomyelitisMesenchymal stem cellQRStem-cell therapyDendritic cellDendritic Cellsmedicine.diseaseCell biologyDevelopmental Biology/Stem CellsMicroscopy Electronstomatognathic diseasesmedicine.anatomical_structureImmune SystemImmunologyBone Morphogenetic ProteinsMedicineFemaleLymph NodesStem cellNeuroscience/Neurobiology of Disease and RegenerationResearch ArticlePLoS ONE
researchProduct

Soft Tissue Sarcomas (STS)

2021

Soft tissue sarcomas (STSs) represent a rare and heterogeneous group of solid tumors derived from mesenchymal progenitors and account for 1% of all adult malignancies. Although in the last decade anthracycline-based chemotherapy single agent or in combination has been able to improve clinical benefits, prognosis is still poor, and STSs represent an important unmet medical need.

ChemotherapyHeterogeneous groupAnthracyclinebusiness.industrymedicine.medical_treatmentMesenchymal stem cellmedicineCancer researchSoft tissueSingle agentProgenitor cellbusiness
researchProduct

New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.

2010

In recent years, human mesenchymal stem cells (MSC) have been extensively studied. Their key characteristics of long-term self-renewal and a capacity to differentiate into diverse mature tissues favour their use in regenerative medicine applications. Stem cells can be found in embryonic and extra-embryonic tissues as well as in adult organs. Several reports indicate that cells of Wharton's jelly (WJ), the main component of umbilical cord extracellular matrix, are multipotent stem cells, expressing markers of bone marrow mesenchymal stem cells (BM-MSC), and giving rise to different cellular types of both connective and nervous tissues. Wharton's jelly mesenchymal stem cells (WJ-MSC) express …

Clinical uses of mesenchymal stem cellsBone Marrow CellsBiologyRegenerative MedicineUmbilical CordImmunomodulationMesodermWharton's jellyAnimalsHumansCell LineageStem cell transplantation for articular cartilage repairCell ProliferationSettore BIO/16 - Anatomia UmanaMultipotent Stem CellsMesenchymal stem cellEndodermCell DifferentiationMesenchymal Stem CellsCell BiologyHematologyCell biologyExtracellular MatrixMultipotent Stem CellAmniotic epithelial cellsImmunologyHepatocytesmesenchymal stem cells umbilical cord Wharton's jelly differentiation hepatocyteStem cellBiomarkersDevelopmental BiologyAdult stem cellStem cells and development
researchProduct

Alternative and complementary therapies in osteoarthritis and cartilage repair

2020

Osteoarthritis (OA) is the most common joint condition and, with a burgeoning ageing population, is due to increase in prevalence. Beyond conventional medical and surgical interventions, there are an increasing number of ‘alternative’ therapies. These alternative therapies may have a limited evidence base and, for this reason, are often only afforded brief reference (or completely excluded) from current OA guidelines. Thus, the aim of this review was to synthesize the current evidence regarding autologous chondrocyte implantation (ACI), mesenchymal stem cell (MSC) therapy, platelet-rich plasma (PRP), vitamin D and other alternative therapies. The majority of studies were in knee OA or chond…

Complementary TherapiesMaleAgingmedicine.medical_specialtyAlternativeMEDLINEPsychological interventionOsteoarthritisReviewPlaceboMesenchymal Stem Cell TransplantationTransplantation Autologous03 medical and health sciences0302 clinical medicineChondrocytesOsteoarthritismedicineVitamin D and neurologyHumansVitamin DIntensive care medicineAutologous chondrocyte implantationddc:616030203 arthritis & rheumatology030222 orthopedicsbusiness.industryCartilageAge FactorsOsteoarthritis Cartilage Alternative Therapy Treatment HerbalVitaminsOsteoarthritis Kneemedicine.diseaseClinical trialTreatmentmedicine.anatomical_structureCartilageTreatment OutcomeHerbalFemaleTherapyGeriatrics and GerontologybusinessAging Clinical and Experimental Research
researchProduct

A Xenogeneic-Free Protocol for Isolation and Expansion of Human Adipose Stem Cells for Clinical Uses

2013

Human adipose stem cells (hASCs) play a crucial role in the fields of regenerative medicine and tissue engineering for different reasons: the abundance of adipose tissue, their easy harvesting, the ability to multipotent differentiation and the fact that they do not trigger allogeneic blood response or secrete cytokines that act as immunosuppressants. The vast majority of protocols use animal origin reagents, with the underlying risk of transmitting infections by non-human pathogens. We have designed a protocol to isolate and maintain the properties of hASCs avoiding xenogeneic reagents. These changes not only preserve hASCs morphology, but also increase cell proliferation and maintain thei…

Cèl·lules mare neuralsCellular differentiationCell- and Tissue-Based TherapyAdipose tissueCell SeparationStem cell markerRegenerative MedicineRegenerative medicine0302 clinical medicineTissue engineeringMolecular Cell BiologyAdipocytesNeurociènciesGene Regulatory Networks0303 health sciencesMultidisciplinaryStem CellsQRGene Expression Regulation DevelopmentalCell Differentiation3. Good healthCell biologyAdult Stem Cells317 Pharmacy030220 oncology & carcinogenesisMedicineStem cellCellular TypesMetabolic Networks and PathwaysResearch ArticleBiotechnologyAdultAdolescentClinical Research DesignScienceCell PotencyPrimary Cell CultureBiologyCell Growth03 medical and health sciencesYoung AdultAnimalsHumansBiology030304 developmental biologyCell ProliferationTissue EngineeringGene Expression ProfilingMesenchymal stem cellCell cultureImmunologyBiomarkersDevelopmental BiologyPLoS ONE
researchProduct

Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance

2020

Abstract Cancer is the leading cause of deaths worldwide and is of great importance. Metastasis-inducing the majority of cancer related deaths is a principal problem in cancer treatment. Therefore, therapy regimes preventing metastasis formation are of prominent importance to improve the outcome of malignant diseases. The epithelial-mesenchymal transition (EMT) is a predominant process associated with the onset of metastasis and converts epithelial cells to mesenchymal cells. In this chapter, we concentrated on three proteins involved in the metastasis and EMT: RKIP, SNAIL, and YY1. Briefly, SNAIL and YY1 are overexpressed in many cancers, while RKIP is downregulated. Therefore, these prote…

DrugbiologyYY1business.industrymedia_common.quotation_subjectMesenchymal stem cellCancerSnailDrug resistancemedicine.diseaseTherapeutic targetingMetastasisbiology.animalmedicineCancer researchbusinessmedia_common
researchProduct

Disruption of apical-basal polarity of human embryonic stem cells enhances hematoendothelial differentiation

2007

Abstract During murine development, the formation of tight junctions and acquisition of polarity are associated with allocation of the blastomeres on the outer surface of the embryo to the trophoblast lineage, whereas the absence of polarization directs cells to the inner cell mass. Here, we report the results of ultrastructural analyses that suggest a similar link between polarization and cell fate in human embryos. In contrast, the five human embryonic stem cell (hESC) lines displayed apical-basal, epithelial-type polarity with electron-dense tight junctions, apical microvilli, and asymmetric distribution of organelles. Consistent with these findings, molecules that are components of tigh…

Embryoid bodyBiologyCell fate determinationMiceCell polarityAnimalsHumansInner cell massCells CulturedEmbryonic Stem Cellsreproductive and urinary physiologyembryoid body formationTight junctionMesenchymal stem cellapical-basal polarityCell PolarityCell DifferentiationEpithelial CellsCell Biologyinner cell masshuman embryonic stem cellsEmbryonic stem cellHematopoiesisCell biologyDrug CombinationsIntercellular JunctionsPhenotypeembryonic structuresMolecular Medicinehernatoendothelial differentiationProteoglycansCollagenEndothelium VascularLamininStem cellDevelopmental Biology
researchProduct

Overexpression of the truncated form of high mobility group a proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation

2014

The pathogenesis of uterine leiomyomas, the most common benign tumor in women, is still unknown. This lack of basic knowledge limits the development of novel non-invasive therapies. Our group has previously demonstrated that leiomyoma side population (SP) cells are present in tumor lesions and act like putative tumor-initiating stemcells in human leiomyoma. Moreover, accumulated evidence demonstrates that these benign tumors of mesenchymal origin are characterized by rearrangements of the High Mobility Group A proteins (HMGA). In this work, we tested the hypothesis that leiomyoma development may be due to overexpression of HMGA2 (encoding high mobility group AT-hook2) in myometrial stem cel…

EmbryologyMice SCID//purl.org/becyt/ford/1 [https]MiceMice Inbred NODProtein IsoformsUterine leiomyomaLeiomyomaStem CellsSOMATIC STEM CELLSObstetrics and GynecologyExonsBioquímica y Biología Molecularfemale genital diseases and pregnancy complicationsGene Expression Regulation NeoplasticCell Transformation NeoplasticLeiomyomaUterine NeoplasmsMyometriumNeoplastic Stem CellsFemaleStem cellHIGH MOBILITY GROUP A PROTEINSCIENCIAS NATURALES Y EXACTASPlasmidsAdult stem cellmedicine.medical_specialtyUTERINE LEIOMYOMASMyocytes Smooth MuscleTransplantation HeterologousBiologyTransfectionHUMAN MYOMETRIUMCiencias BiológicasHMGA2Side populationInternal medicineGeneticsmedicineAnimalsHumans//purl.org/becyt/ford/1.6 [https]neoplasmsMolecular BiologyHMGA2 ProteinMesenchymal stem cellHMGASIDE POPULATIONCell Biologymedicine.diseaseIntronsEndocrinologyReproductive MedicineCancer researchbiology.proteinDevelopmental Biology
researchProduct

Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types.

2009

Aims: An extensive colonization of surgical meshes with autologous fibroblasts may reduce complications. Therefore, we aimed to establish a technique that allows isolation and propagation of fibroblasts from vaginal biopsies. Using these cells we tested the applicability of several clinically applied meshes for fibroblast coating. Materials & methods: Fibroblasts were isolated from vaginal tissue after digestion with collagenase. Characterization was performed by immunostaining for cytokeratin 5, 6 and 14, smooth muscle actin and vimentin. A semiquantitative technique was applied to determine the degree of mesh coating 5 h and 5 weeks after seeding of fibroblasts. Seven meshes of diffe…

EmbryologyPathologymedicine.medical_specialtyBiomedical EngineeringCell Culture TechniquesVimentinPolypropylenesCytokeratinMaterials TestingmedicineHumansTransplantation HomologousFibroblastCell ProliferationbiologyTissue EngineeringChemistryMesenchymal stem cellProstheses and ImplantsFibroblastsPlastic Surgery ProceduresSurgical MeshTransplantationmedicine.anatomical_structureCell cultureVaginaCollagenasebiology.proteinFemaleImmunostainingmedicine.drugRegenerative medicine
researchProduct

Interaction between mesenchymal cells and the posterior iris epithelium in chicken embryos

1977

The iris anlage of 3--10 day old chicken embryos was studied by both light and electron microscopy. Serial semithin sections showed that some of the mesenchymal cells overlying the eye cup moved into the primitive eye cavity by the 3rd day of incubation. On the 4th day some of these cells came into close contact with the basement membrane of the dorsal iris epithelium. The bases of the epithelial cells were flat at this stage. Towards the 10th day they formed cytoplasmic processes which did not penetrate the basement membrane. Fine mesenchymal cytoplasmic processes and a large number of extracellular fibrils developed in the epithelial--mesenchymal interface. The fine mesenchymal processes …

EmbryologyTime FactorsIrisChick EmbryoBiologyEndoplasmic ReticulumFibrilBasement MembraneEpitheliumlaw.inventionMesodermCell MovementlawmedicineAnimalsIris (anatomy)Basement membraneEndoplasmic reticulumMesenchymal stem cellCell DifferentiationCell BiologyAnatomyEpitheliumMicroscopy Electronmedicine.anatomical_structureCytoplasmAnatomyElectron microscopeDevelopmental BiologyAnatomy and Embryology
researchProduct